Skip to main content
Guests homeNews home
Story
1 of 19

Biseach Symposium Strengthens Cancer Research Partnership Between Notre Dame and University of Galway

A group of approximately 30 people stands posed for a photo in front of a stone building with a sign reading "Biseach Initiative, University of Notre Dame."  They are wearing a variety of business casual clothing and conference badges.
Photo by Andrew Downes

A team of researchers from the University of Notre Dame (South Bend, Indiana, USA) joined scientists, engineers, and civic leaders at University of Galway (Galway City, County Galway, Ireland) as part of an ambitious transatlantic effort to transform cancer research and care. The gathering, known as the Biseach Symposium, marked a significant milestone in the Biseach Initiative, a strategic collaboration designed to build on the talent, cancer expertise, infrastructure, and innovative spirit of both universities to improve cancer outcomes globally.

The initiative is co-led by Sharon Stack, the Ann F. Dunne & Elizabeth Riley Director of Notre Dame’s Harper Cancer Research Institute, and Michael Kerin, Professor and Chair of Surgery at the University of Galway's Cancer Centre.

Moving from Ideas to Impact

A man in a blue sport coat and khaki pants gestures while presenting research related to the Biseach Initiative on a large screen bearing the University of Notre Dame logo.
Photo by Angelic Rose Hubert

Held over two days at University of Galway’s O'Donoghue Centre, the symposium featured research presentations, collaborative workshops, and high-energy "collision" sessions designed to spark new research projects and inter-disciplinary transatlantic collaborations. The goal was to foster deeper collaboration aimed at generating new approaches to cancer diagnosis, treatment, and care.

“This initiative is about taking on grand challenges in cancer research,” said Stack, who also serves as the Kleiderer-Pezold Professor of Biochemistry at Notre Dame. “And to do that, we need big ideas, but we also need to prepare and empower scientists and engineers to move from ideas to action—translating basic discoveries into better outcomes for patients.”

Kerin emphasized that the name Biseach—an Irish word meaning “to heal, make better, or improve”—embodies the core mission of the collaboration.

“All great research begins with a real clinical problem,” Kerin said. “Here in the west of Ireland, we serve one of the country’s most rural and economically deprived populations. Access to cancer care is limited, and survival rates are the lowest in the nation. Through the Biseach Initiative, we’re working with Notre Dame to develop therapies that not only meet our urgent local needs but have a global impact.”

Deepening a Transatlantic Partnership

Peter Keane, Mayor of Galway City, highlighted the broader significance of the initiative, tying it to a 2023 Memorandum of Understanding between the two universities.

"The 2023 Memorandum of Understanding between the University of Notre Dame and University of Galway marked a pivotal moment in our shared mission to build strong interdisciplinary cancer research collaborations," Keane said. "The vision behind that agreement was clear: to bring together the brightest minds across disciplines, borders, and institutions to tackle one of the most pressing health challenges of our time. Today, through the Biseach Initiative, we see that vision coming to life. This initiative, grounded in the shared goal of improving cancer outcomes through collaborative research, is not only advancing scientific discovery, but more importantly, it is giving hope and improving care for cancer patients and their families. And that is the true metric of its impact."

Four people in business attire converse; a woman with gray hair gestures while speaking to a man in a blue suit and tie.  Another man in a suit stands to the left, and a man wearing a mayoral chain stands to the right.
Photo by Angelic Rose Hubert

Keane also emphasized that the collaboration is important for each university's respective city and broader region.

"I want to reaffirm Galway City's commitment to supporting and strengthening the ties between our two universities, between our cities and indeed between our communities,” Keane said. “There is so much more that we can achieve together in research, innovation, education and indeed in enterprise. Let us continue to build on this strong foundation and let us deepen our partnerships."

Combining Research, Education, and Innovation

Two people sit at a table conversing. A man in a blue jacket holds a phone, and a woman in a patterned blue and brown shirt smiles while holding papers and a pen.  A laptop and water bottle sit on the maroon tablecloth between them.
Photo by Angelic Rose Hubert

Among the attendees was Mark Lawler, Associate Pro-Vice-Chancellor and Professor of Digital Health at Queen’s University Belfast, who underscored the importance of unity in cancer research.

"This collaboration is all about the people,” Lawler said, “Yes, we're each trying to do the right thing, but it's also about how we work together. It's no use if we're competing against each other. Cancer is a global issue; we have to compete together against cancer."

Faculty talks during the symposium covered a wide range of clinical and research advances—including novel approaches to treating glioblastoma, lymphoma, ovarian cancer, multiple myeloma, colorectal cancer, and breast cancer. Notre Dame researchers highlighted the university’s strengths in imaging, drug discovery, genomics, and bioinformatics. University of Galway faculty discussed plans to provide cancer tissue samples to enhance Notre Dame’s research and also shared updates about new investments in the university’s Institute for Clinical Trials and Institute for Health Discovery and Innovation, which will help streamline development of therapies and technologies, by spanning the pipeline of cancer research from fundamental and discovery research, biomedical engineering, and applied and translational research.

Fostering a Research Friendship

To support the Biseach Initiative, dozens of researchers from the two universities have crossed the Atlantic, often for long-term stays. The collaboration has also been especially beneficial for several undergraduate and graduate students who have had the opportunity to conduct research in labs in both locations.

Eight individuals stand for a photo in front of banners for the University of Galway and the BISEACH initiative.
Participants from the University of Notre Dame included (from the left) Andy Bullock, Lisa Caulfield, Xin Lu, Glen Niebur, Donny Hanjaya-Putra, Meenal Datta, Pinar Zorlutuna, Herman Sintim, and Sharon Stack. Photo by Andrew Downes

Kerin noted that this exchange has resulted in a trusting relationship that drives greater innovation. “One thing that strikes me about this collaboration is the friendship and the ability to work together that we have developed. If you have that, you can achieve an enormous amount,” he said.

Stack agreed, stating, "Research cures cancer. Every new scan, every new surgical tool, every new therapy comes from basic lab research at one point or another. I can't think of a better group to collaborate with, and I can't think of a better place to innovate. We're stronger together."

Contact

Brett Beasley / Research Content Strategy Program Director

Notre Dame Research / University of Notre Dame

bbeasle1@nd.edu / +1 574-631-8183

research.nd.edu / @UNDResearch

About Notre Dame Research

The University of Notre Dame is a private research and teaching university inspired by its Catholic mission. Located in South Bend, Indiana, its researchers are advancing human understanding through research, scholarship, education, and creative endeavor in order to be a repository for knowledge and a powerful means for doing good in the world. For more information, please see research.nd.edu or @UNDResearch.

Latest Research